The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia

Cited by (1,019)

Items 701–800 of 1,019

1. Midostaurin improves quality of life and mediator-related symptoms in advanced systemic mastocytosis
   Karin Hartmann, Jason R. Gotlib, Cem Akin, Olivier Hermine, Farrukh Tauseef Awan, Elizabeth Olson Hexner, Michael J. Mauro, Hans Dietrich Menssen, Suman Redhu, Stefanie Knoll et al. · 2020 · Journal of Allergy and Clinical Immunology
2. Novel manifestations of immune dysregulation and granule defects in gray platelet syndrome
   Matthew C. Sims, Louisa Mayer, Janine Collins, Tadbir K. Bariana, Karyn Mégy, Cécile Lavenu‐Bombled, Denis Seyres, Laxmikanth Kollipara, Frances Burden, Daniel J. Greene et al. · 2020 · Blood
3. Understanding Sideroblastic Anemia: An Overview of Genetics, Epidemiology, Pathophysiology and Current Therapeutic Options
   Ghaith F. Abu-Zeinah, Maria Teresa DeSancho · 2020 · Journal of Blood Medicine
4. Next-Generation Sequencing of DDX41 in Myeloid Neoplasms Leads to Increased Detection of Germline Alterations
   Sarah A. Bannon, Mark J. Routbort, Guillermo Montalban Bravo, Rohtesh S. Mehta, Fatima Zahra Jelloul, Koichi Takahashi, Naval Guastad Daver, Betül Oran, Naveen Pemmaraju, Gautam M. Borthakur et al. · 2021 · Frontiers in Oncology
5. VEXAS syndrome in myelodysplastic syndrome with autoimmune disorder
   Huijun Huang, Wenjun Zhang, Wenyu Cai, Jinqin Liu, Huijun Wang, Tiejun Qin, Zefeng Xu, Bing Li, Shiqiang Qu, Lijuan Pan et al. · 2021 · Experimental Hematology and Oncology
6. The Importance of Cellular Metabolic Pathways in Pathogenesis and Selective Treatments of Hematological Malignancies
   Mojdeh Soltani, Yue Zhao, Zhijia Xia, Mazdak Ganjalıkhani-Hakemi, Alexandr V. Bazhin · 2021 · Frontiers in Oncology
7. Circular RNAs in acute myeloid leukemia
   Vijendra Singh, Md. Hafiz Uddin, Jeffrey A. Zonder, Asfar Sohail Azmi, Suresh Kumar Balasubramanian · 2021 · Molecular Cancer
8. Early T-Cell Precursor Acute Lymphoblastic Leukemia: Diagnosis, Updates in Molecular Pathogenesis, Management, and Novel Therapies
   Chun‐Fung Sin, Pui-hei Marcus Man · 2021 · Frontiers in Oncology
9. Clinical characteristics, treatment, and prognosis of 118 cases of myeloid sarcoma
   Haiqiu Zhao, Zhenkun Dong, Dingming Wan, Weijie Cao, Haizhou Xing, Zhenzhen Liu, Jixin Fan, Haiqiong Wang, Runqing Lu, Yinyin Zhang et al. · 2022 · Scientific Reports
10. Characterization of therapy-related acute myeloid leukemia: increasing incidence and prognostic implications
    Christer C. Nilsson, Fredrika Linde, Erik Hulegårdh, Hege Gravdahl Garelius, Vladimir Lazarević, Petar Antunović, Jörg Cammenga, Stefan Deneberg, Anna Eriksson, Martin Jädersten et al. · 2022 · Haematologica
11. Hereditary platelet disorders associated with germ line variants in RUNX1, ETV6, and ANKRD26
    Claire C. Homan, Hamish S. Scott, Anna L Brown · 2023 · Blood
12. A randomized comparison of CPX-351 and FLAG-Ida in adverse karyotype AML and high-risk MDS: the UK NCRI AML19 trial
    Jad Othman, Charlotte S. Wilhelm-Benartzi, Richard James Dillon, Steven Knapper, Sylvie D. Freeman, Leona M. Batten, Joanna E. Canham, Emily Laura Hinson, Julie Wych, Sophie Betteridge et al. · 2023 · Blood Advances
13. Detection of prognostically relevant mutations and translocations in myeloid sarcoma by next generation sequencing
    Karl Kashofer, Max Gornicec, KARIN LIND, Veronica Caraffini, Silvia Schauer, Christine Beham‐Schmid, Albert Wölfler, Gerald Höefler, Heinz Sill, Armin Zebisch · 2017 · Leukemia & lymphoma/Leukemia and lymphoma
14. Therapy related‐chronic myelomonocytic leukemia (CMML): Molecular, cytogenetic, and clinical distinctions from de novo CMML
    Mrinal M. Patnaik, Rangit Reddy Vallapureddy, Fevzi Yalniz, Curtis A. Hanson, Rhett P. Ketterling, Terra L. Lasho, Christy M. Finke, Aref Al‐Kali, Naseema Gangat, Ayalew Tefferi · 2017 · American Journal of Hematology
15. CSF3R Mutations are frequently associated with abnormalities of RUNX1, CBFB, CEBPA, and NPM1 genes in acute myeloid leukemia
    Yang Zhang, Fang Wang, Xue Chen, Yu Zhang, Mingyu Wang, Hong Liu, Panxiang Cao, Xiaoli Ma, Tong Wang, Jianping Zhang et al. · 2018 · Cancer
16. Dasatinib and navitoclax act synergistically to target NUP98-NSD1+/FLT3-ITD+ acute myeloid leukemia
    Jarno L. Kivioja, Angeliki Thanasopoulou, Ashwini Kumar, Mika Kontro, Bhagwan Yadav, Muntasir Mamun Majumder, Komal Kumar Javarappa, Samuli Eldfors, Juerg Schwaller, Kimmo Porkka et al. · 2018 · Leukemia
17. Eltrombopag in Immune Thrombocytopenia, Aplastic Anemia, and Myelodysplastic Syndrome: From Megakaryopoiesis to Immunomodulation
    Bruno Fattizzo, Giorgia Virginia Levati, Ramona Cassin, Wilma Barcellini · 2019 · Drugs
18. Validation of the IPSET score for thrombosis in patients with prefibrotic myelofibrosis
    Paola Guglielmelli, Alessandra Carobbio, Elisa Rumi, Valerio De Stefano, Lara Mannelli, Francesco Mannelli, Giada Rotunno, Giacomo Coltro, Silvia Betti, Chiara Cavalloni et al. · 2020 · Blood Cancer Journal
19. The Diagnostic Work-Up of Hypereosinophilia
    Sa A. Wang · 2018 · Pathobiology
20. Pathogenesis and Management of Thrombotic Disease in Myeloproliferative Neoplasms
    Deepa J. Arachchillage, Michael Laffan · 2019 · Seminars in Thrombosis and Hemostasis
21. A provider's guide to primary myelofibrosis: pathophysiology, diagnosis, and management
    Benjamin Garmezy, Jordan K. Schaefer, Jessica Mercer, Moshe Talpaz · 2020 · Blood Reviews
22. Comparison of the International Consensus and 5th WHO edition classifications of adult myelodysplastic syndromes and acute myeloid leukemia
    Brunangelo Falini, Maria Paola Martelli · 2023 · American Journal of Hematology
23. Molecular and clinical presentation of UBA1 -mutated myelodysplastic syndromes
    Maria Sirenko, Elsa Bernard, Maria Creignou, Dylan Domenico, Andrea Farina, Juan Arango Ossa, Olivier Kosmider, Robert Paul Hasserjian, Martin Jädersten, Ulrich Germing et al. · 2024 · Blood
24. GSH exhaustion via inhibition of xCT-GSH-GPX4 pathway synergistically enhanced DSF/Cu-induced cuproptosis in myelodysplastic syndromes
    Yanchun Li, Yanchun Li, Yanhua Yu, Xueying Ren, Chen Yang, Weidong Jin, Keyi Li, Yi Zhou, Cuiyun Wu, Yuhuan Shen et al. · 2024 · Free Radical Biology and Medicine
25. When clinical heterogeneity exceeds genetic heterogeneity: thinking outside the genomic box in chronic myelomonocytic leukemia
    Markus Ball, Alan F. List, Eric Padron · 2016 · Blood
26. Coexisting and cooperating mutations in NPM1 -mutated acute myeloid leukemia
    Jay L. Patel, Jonathan A. Schumacher, Kimberly Frizzell, Shelly Sorrells, Wei Shen, Adam L. Clayton, Rakhi P. Jattani, Todd W. Kelley · 2017 · Leukemia Research
27. Characteristics and outcomes of older patients with secondary acute myeloid leukemia according to treatment approach
    Prajwal Chaitanya Boddu, Hagop M. Kantarjian, Farhad Ravandi, Guillermo Garcia‐Manero, Srđan Verstovšek, Elias Joseph Jabbour, Koichi Takahashi, Kapil N. Bhalla, Marina Y Konopleva, Courtney Denton Dinardo et al. · 2017 · Cancer
28. The relative utilities of genome-wide, gene panel, and individual gene sequencing in clinical practice
    Frank C. Kuo, Brenton G. Mar, Robert Coleman Lindsley, Neal Ian Lindeman · 2017 · Blood
29. Heterogeneity of GATA2-related myeloid neoplasms
    Shinsuke Hirabayashi, Marcin W. Włodarski, Emilia J. Kozyra, Charlotte Marie Niemeyer · 2017 · International Journal of Hematology
30. Acute Myeloid Leukemia Immunophenotyping by Flow Cytometric Analysis
    Xueyan Chen, Sindhu Cherian · 2017 · Clinics in Laboratory Medicine
31. GATA2 monoallelic expression underlies reduced penetrance in inherited GATA2-mutated MDS/AML
    Ahad Al Seraihi, Ana Rio‐Machín, Kiran Tawana, Csaba Bödör, Jun Wang, A. Nagano, James A. Heward, Sameena Iqbal, Steven Best, Nicholas C. Lea et al. · 2018 · Leukemia
32. Review article: a multidisciplinary approach to the diagnosis and management of Budd‐Chiari syndrome
    Faisal Khan, Matthew James Armstrong, Homoyon Mehrzad, Frederick E. Chen, Neil Desley, Rachel Mary Brown, Owen Lawrence Cain, Dhiraj Tripathi · 2019 · Alimentary Pharmacology & Therapeutics
33. Blast Transformation in Myeloproliferative Neoplasms: Risk Factors, Biological Findings, and Targeted Therapeutic Options
    Alessandra Iurlo, Daniele Cattaneo, Umberto Gianelli · 2019 · International Journal of Molecular Sciences
34. Genomic landscape of MDS/CMML associated with systemic inflammatory and autoimmune disease
    Lin‐Pierre Zhao, Maxime Boy, Célia Azoulay, Emmanuelle Clappier, Marie Sébert, Ludivine Amable, Jihène Klibi, Kamel Benlagha, Marion Espéli, Karl Balabanian et al. · 2021 · Leukemia
35. VEXAS syndrome in a patient with previous spondyloarthritis with a favourable response to intravenous immunoglobulin and anti-IL17 therapy
    Marion Magnol, Loukianos Couvaras, Yannick Degboé, Éric Delabesse, Cristina Bulai Livideanu, Adeline Ruyssen‐Witrand, Arnaud Constantin · 2021 · Lara D. Veeken
36. Ophthalmic Manifestations of Acute Leukemia
    Mohammad Hafeez, Muhammad Hassaan Ali, Nimra Najib, Muhammad Hammad Ayub, Kaleem Shafi, Mubashar Munir, Nadeem Hafeez Butt · 2019 · Cureus
37. The Prenatal Origin of Childhood Leukemia: Potential Applications for Epidemiology and Newborn Screening
    Erin L. Marcotte, Logan G. Spector, Daniela Palheiro Mendes-de-Almeida, Heather H. Nelson · 2021 · Frontiers in Pediatrics
38. AML with germline DDX41 variants is a clinicopathologically distinct entity with an indolent clinical course and favorable outcome
    Peng Li, Thomas White, Wei Xie, Wei Cui, Deniz Peker, Gang Zeng, Huan‐You Wang, Jennie Vagher, Sara Brown, Margaret Williams et al. · 2021 · Leukemia
39. Demethylation and Up-Regulation of an Oncogene after Hypomethylating Therapy
    Yao‐Chung Liu, Junsu Kwon, Emiliano Fabiani, Zhijian Xiao, Yanjing V. Liu, Matilde Y. Follo, Jinqin Liu, Huijun Huang, Chong Gao, Jun Liu et al. · 2022 · New England Journal of Medicine
40. Clinical applications of MALDI imaging technologies in cancer and neurodegenerative diseases
    Yasemin Uçal, Zeynep A. Oztug Durer, Hakan Atak, Elif Kadioglu, Betül Şahin, Abdurrahman Coşkun, Ahmet Tarık Baykal, Aysel Özpınar · 2017 · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
41. Monocytosis in polycythemia vera: Clinical and molecular correlates
    Daniela Barraco, Sonia Cerquozzi, Naseema Gangat, Mrinal M. Patnaik, Terra L. Lasho, Christy M. Finke, Curtis A. Hanson, Rhett P. Ketterling, Animesh Dev Pardanani, Ayalew Tefferi · 2017 · American Journal of Hematology
42. Preparing Viable Single Cells from Human Tissue and Tumors for Cytomic Analysis
    Nalin Leelatian, Deon Bryant Doxie, Allison R. Greenplate, Justine Sinnaeve, Rebecca A. Ihrie, Jonathan Michael Irish · 2017 · Current Protocols in Molecular Biology
43. Transplant Outcomes for Secondary Acute Myeloid Leukemia: Acute Leukemia Working Party of the European Society for Blood and Bone Marrow Transplantation Study
    Salyka M. Sengsayadeth, Myriam Labopin, Ariane Boumendil, Jürgen Finke, Arnold Ganser, Matthias Stelljes, Gerhard Ehninger, Dietrich Wilhelm Beelen, Dietger W. Niederwieser, Didier Blaise et al. · 2018 · Transplantation and Cellular Therapy
44. Therapy-related acute lymphoblastic leukemia has distinct clinical and cytogenetic features compared to de novo acute lymphoblastic leukemia, but outcomes are comparable in transplanted patients
    Ibrahim Taha Aldoss, Tracey Stiller, Ni‐Chun Tsai, Joo Young Song, Thai M. Cao, N. Achini Bandara, Amandeep Salhotra, Samer K. Khaled, Ahmed M. Aribi, Monzr M. Al Malki et al. · 2018 · Haematologica
45. Circular RNA regulatory network reveals cell–cell crosstalk in acute myeloid leukemia extramedullary infiltration
    Chengfang Lv, Lili Sun, Zhibo Guo, Huibo Li, Desheng Kong, Bingqi Xu, Leilei Lin, Tianjiao Liu, Dan Guo, Jin Zhou et al. · 2018 · Journal of Translational Medicine
46. Residential ambient benzene exposure in the United States and subsequent risk of hematologic malignancies
    Lauren R. Teras, W. Ryan Diver, Emily L. Deubler, Daniel R. Krewski, Christopher R. Flowers, Jeffrey M. Switchenko, Susan M. Gapstur · 2019 · International Journal of Cancer
47. Myeloid‐Derived Suppressor Cells in Hematologic Diseases: Promising Biomarkers and Treatment Targets
    Nikoleta Bizymi, Sunčica Bjelica, Astrid Olsnes Kittang, Slavko B. Mojsilović, Maria Velegraki, Charalampos G. Pontikoglou, Mikaël Roussel, Elisabeth Ersvær, Juan Francisco Santibanez, Marie Lipoldová et al. · 2019 · HemaSphere
48. Therapy-related acute lymphoblastic leukemia is a distinct entity with adverse genetic features and clinical outcomes
    Caner Saygin, Ashwin Kishtagari, Ryan Daniel Cassaday, Natalie Marie Reizine, Ilana R. Yurkiewicz, Michaela Liedtke, Wendy Stock, Richard A. Larson, Ross L. Levine, Martin S. Tallman et al. · 2019 · Blood Advances
49. Overexpression of TIGIT in NK and T Cells Contributes to Tumor Immune Escape in Myelodysplastic Syndromes
    Fanqiao Meng, Lijuan Li, Fengzhu Lu, Jing Yue, Zhaoyun Liu, Wei Zhang, Rong Fu · 2020 · Frontiers in Oncology
50. Pediatric MDS and bone marrow failure-associated germline mutations in SAMD9 and SAMD9L impair multiple pathways in primary hematopoietic cells
    Melvin E. Thomas, Sherif Abdelhamed, Ryan Hiltenbrand, Jason R. Schwartz, Sadie Miki Sakurada, Michael Francis Walsh, Guangchun Song, Jing Ma, Shondra M. Pruett‐Miller, Jeffery M. Klco · 2021 · Leukemia
51. Cellular Heterogeneity of Mesenchymal Stem/Stromal Cells in the Bone Marrow
    Yo Mabuchi, Chikako Okawara, Simón Méndez‐Ferrer, Chihiro Akazawa · 2021 · Frontiers in Cell and Developmental Biology
52. The utility of next‐generation sequencing in diagnosis and monitoring of acute myeloid leukemia and myelodysplastic syndromes
    Eric J. Duncavage, Bevan Tandon · 2015 · International Journal of Laboratory Hematology
53. Oncogene-independent BCR-like signaling adaptation confers drug resistance in Ph-like ALL
    Christian Hurtz, Gerald B. W. Wertheim, Joseph P. Loftus, Daniel Blumenthal, Anne W. Lehman, Yong Li, Asen Bagashev, Bryan S. Manning, Katherine D. Cummins, Janis K. Burkhardt et al. · 2020 · Journal of Clinical Investigation
54. Human erythroleukemia genetics and transcriptomes identify master transcription factors as functional disease drivers
    Alexandre Fagnan, Frederik Otzen Bagger, Maria‐Riera Piqué‐Borràs, Cathy Ignacimouttou, Alexis Caulier, Cécile K. Lopez, Elie Robert, Benjamin Uzan, Véronique Gelsi‐Boyer, Zakia Aid et al. · 2020 · Blood
55. BiTEs, DARTS, BiKEs and TriKEs—Are Antibody Based Therapies Changing the Future Treatment of AML?
    Cecily Allen, Amer Methqal Zeidan, Jan Philipp Bewersdorf · 2021 · Life
56. Dysregulation of miRNA in Leukemia: Exploiting miRNA Expression Profiles as Biomarkers
    Luisa Anelli, Antonella Zagaria, Giorgina Specchia, Pellegrino Musto, Francesco Albano · 2021 · International Journal of Molecular Sciences
57. Inflammatory Cytokines Shape an Altered Immune Response During Myeloid Malignancies
    Virginia Camacho, Valeriya Kuznetsova, Robert S. Welner · 2021 · Frontiers in Immunology
58. Decitabine Versus Hydroxyurea for Advanced Proliferative Chronic Myelomonocytic Leukemia: Results of a Randomized Phase III Trial Within the EMSCO Network
    Raphaël Itzykson, Valeria Santini, Sylvain Thépot, Lionel Adès, Cendrine Chaffaut, Aristoteles A. N. Giagounidis, Margot Morabito, Nathalie M Droin, Michael Lübbert, Rosa Sapena et al. · 2022 · Journal of Clinical Oncology
59. Number and type of TET2 mutations in chronic myelomonocytic leukemia and their clinical relevance
    Mrinal M. Patnaik, Mohammad Faizan Zahid, Terra L. Lasho, Christy M. Finke, Rhett Ketterling, Naseema Gangat, Keith D. Robertson, Curtis A. Hanson, Ayalew Tefferi · 2016 · Blood Cancer Journal
60. Clinical utility of gene panel-based testing for hereditary myelodysplastic syndrome/acute leukemia predisposition syndromes
    Lucia Guidugli, Amy Knight Johnson, Gorka Alkorta‐Aranburu, Viswateja Nelakuditi, Kelly Arndt, Jane E. Churpek, Lucy A. Godley, D. Townsley, Neal S. Young, Carrie A. Fitzpatrick et al. · 2017 · Leukemia
61. Feasibility of allogeneic stem-cell transplantation after azacitidine bridge in higher-risk myelodysplastic syndromes and low blast count acute myeloid leukemia: results of the BMT-AZA prospective study
    Maria Teresa Voso, Giuseppe G.M. Leone, Alfonso Piciocchi, Luana Fianchi, Stella Santarone, Anna Candoni, Marianna Criscuolo, Arianna Masciulli, Elisa Cerqui, Alfredo Molteni et al. · 2017 · Annals of Oncology
62. Imatinib in myeloid/lymphoid neoplasms with eosinophilia and rearrangement of PDGFRB in chronic or blast phase
    Mohamad Jawhar, Nicole Naumann, Juliana Schwaab, Herrad Baurmann, Jochen Casper, Tu‐Anh Dang, Lutz Dietze, Konstanze Döhner, Annette Hänel, B. Lathan et al. · 2017 · Annals of Hematology
63. Significance of thrombocytopenia in patients with primary and postessential thrombocythemia/polycythemia vera myelofibrosis
    Lucia Masárová, Ahmad Alhuraiji, Prithviraj Bose, Naval Guastad Daver, Naveen Pemmaraju, Jörge E. Cortes, Sherry A. Pierce, Hagop M. Kantarjian, Srđan Verstovšek · 2017 · European Journal Of Haematology
64. Epidemiology, outcome, and risk factors for infectious complications in myelofibrosis patients receiving ruxolitinib: A multicenter study on 446 patients
    Nicola Polverelli, Giuseppe A. Palumbo, Gianni Binotto, Elisabetta Abruzzese, Giulia Benevolo, Micaela Bergamaschi, Alessia Tieghi, Massimiliano Bonifacio, Massimo Breccia, Lucia Catani et al. · 2018 · Hematological Oncology
65. A parsimonious 3-gene signature predicts clinical outcomes in an acute myeloid leukemia multicohort study
    Sarah Wagner, Jayakumar Narayanan Vadakekolathu, Sarah Kathleen Tasian, Heidi Altmann, Martin Bornhäuser, Alan Graham Pockley, Graham Ball, Sergio Rutella · 2019 · Blood Advances
66. ASXL1 mutations predict inferior molecular response to nilotinib treatment in chronic myeloid leukemia
    Schönfeld, Lioba, Rinke, Jenny, Hinze, Anna, Nagel, Saskia N., Schäfer, Vivien, Schenk, Thomas, Fabisch, Christian, Brümmendorf, Tim H., Burchert, Andreas, le Coutre, Philipp et al. · 2022 · Leukemia
67. Therapy for lower-risk MDS
    Hetty E. Carraway, Caner Saygin · 2020 · Hematology
68. Clonal hematopoiesis with JAK2V617F promotes pulmonary hypertension with ALK1 upregulation in lung neutrophils
    Yusuke Kimishima, Tomofumi Misaka, Tetsuro Yokokawa, Kento Wada, Koki Ueda, Koichi Sugimoto, Keiji Minakawa, Kazuhiko Nakazato, Takafumi Ishida, Motohiko Oshima et al. · 2021 · Nature Communications
69. Lymphoblastic Lymphoma: a Concise Review
    Tamara Intermesoli, Alessandra Weber, Matteo Leoncin, Luca Frison, Cristina Skert, Renato Bassan · 2022 · Current Oncology Reports
70. Digital Droplet PCR in Hematologic Malignancies: A New Useful Molecular Tool
    Sara Galimberti, Serena Balducci, Francesca Guerrini, Marzia Del Re, Rossella Rosaria Cacciola · 2022 · Diagnostics
71. Allogeneic CD5-specific CAR-T therapy for relapsed/refractory T-ALL: a phase 1 trial
    Jing Pan, Yue Tan, Lingling Shan, Samuel Seery, Biping Deng, Zhuojun Ling, Jinlong Xu, Jiajia Duan, Zelin Wang, Kai Wang et al. · 2024 · Nature Medicine
72. Classification and risk stratification in T-lineage acute lymphoblastic leukemia
    Petri Pölönen, Charles Grenfell Mullighan, David T. Teachey · 2024 · Blood
73. Comprehensive genomic analysis reveals FLT3 activation and a therapeutic strategy for a patient with relapsed adult B-lymphoblastic leukemia
    Malachi Griffith, Obi L. Griffith, Kilannin Krysiak, Zachary L. Skidmore, Matthew J Christopher, Jeffery M. Klco, Avinash Ramu, Tamara Westover, Alex Handler Wagner, Katie Marie Campbell et al. · 2016 · Experimental Hematology
74. Acute myeloid leukemia – strategies and challenges for targeting oncogenic Hedgehog/GLI signaling
    Fritz Aberger, Evelyn Hutterer, Christina Sternberg, Pedro J. del Burgo, Tanja Nicole Hartmann · 2017 · Cell Communication and Signaling
75. CMML: Clinical and molecular aspects
    Raphaël Itzykson, Matthieu Duchmann, Nolwenn Lucas, Éric Solary · 2017 · International Journal of Hematology
76. Differential effects on gene transcription and hematopoietic differentiation correlate with GATA2 mutant disease phenotypes
    Chan-Eng Chong, P. Venugopal, P. Stokes, Y.-K.-Lee-Y.-K. Lee, P. Brautigan, Dto Yeung, M. Babic, Gary R. Engler, S. Lane, M. Klingler-Hoffmann et al. · 2017 · Leukemia
77. Heme oxygenase-1: A new druggable target in the management of chronic and acute myeloid leukemia
    Loredana Salerno, Giuseppe Romeo, Maria Nunziata Modica, Emanuele Amata, Valeria Sorrenti, Ignazio Alberto Barbagallo, Valeria Pittalà · 2017 · European Journal of Medicinal Chemistry
78. Minimal residual disease quantification by flow cytometry provides reliable risk stratification in T-cell acute lymphoblastic leukemia
    Signe Modvig, HANS OLE MADSEN, Sanna M. Siitonen, Susanne Rosthøj, Anne Maria Tierens, Vesa Juvonen, Liv Osnes, Helen Vålerhaugen, Magnus Hultdin, Ingrid Thörn et al. · 2018 · Leukemia
79. Leukemic Involvement in the Thorax
    Girish S. Shroff, Mylene T. Truong, Brett W. Carter, Marcelo Felipe Kuperman Benveniste, Rashmi Kanagal‐Shamanna, Greg Rauch, Chitra Viswanathan, Prajwal Chaitanya Boddu, Naval Guastad Daver, Carol C. Wu · 2019 · Radiographics
80. Haploidentical versus HLA-matched sibling transplantation for refractory acute leukemia undergoing sequential intensified conditioning followed by DLI: an analysis from two prospective data
    Sijian Yu, Fen Huang, Zhiping Fan, Li Xuan, Danian Nie, Yajing Xu, Ting Yang, Shunqing Wang, Zujun Jiang, Na Xu et al. · 2020 · Journal of Hematology & Oncology
81. CPX-351 treatment in secondary acute myeloblastic leukemia is effective and improves the feasibility of allogeneic stem cell transplantation: results of the Italian compassionate use program
    Fabio Guolo, Luana Fianchi, Paola Minetto, Marino Clavio, Michele Gottardi, Sara Galimberti, Giuliana Rizzuto, Michela Rondoni, Giambattista Bertani, Michela Dargenio et al. · 2020 · Blood Cancer Journal
82. Accuracy of SIE/SIES/GITMO Consensus Criteria for Unfitness to Predict Early Mortality After Intensive Chemotherapy in Adults With AML or Other High-Grade Myeloid Neoplasm
    Raffaele Palmieri, Megan K. D. Othus, Anna B. Halpern, Mary‐Elizabeth M. Percival, Colin D. Godwin, Pamela Sue Becker, Roland B. Walter · 2020 · Journal of Clinical Oncology
83. Phase 1 study of lenzilumab, a recombinant anti–human GM-CSF antibody, for chronic myelomonocytic leukemia
    Mrinal M. Patnaik, David Andrew Sallman, Abhishek Avinash Mangaonkar, Rachel Heuer, Jeffery Hirvela, Darci Zblewski, Aref Al‐Kali, Moritz Binder, Maria E. Balasis, Hannah Newman et al. · 2020 · Blood
84. Nucleophosmin in Its Interaction with Ligands
    Ilaria Cela, Adele Di Matteo, Luca Federici · 2020 · International Journal of Molecular Sciences
85. Significance of NPM1 Gene Mutations in AML
    Andrew Hindley, Mark Alexander Catherwood, Mary Frances McMullin, Ken Mills · 2021 · International Journal of Molecular Sciences
86. Mastocytosis and Mast Cell Activation Disorders: Clearing the Air
    Clayton Webster Jackson, Cristina Marie Pratt, Chase Preston Rupprecht, Debendra Pattanaik, Guha A. Krishnaswamy · 2021 · International Journal of Molecular Sciences
87. JAK2 unmutated erythrocytosis: 2023 Update on diagnosis and management
    Naseema Gangat, Natasha Szuber, Ayalew Tefferi · 2023 · American Journal of Hematology
88. Luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): primary analysis of a phase 3, open-label, randomised, controlled trial
    Matteo Giovanni Della Porta, Guillermo Garcia‐Manero, Valeria Santini, Amer Methqal Zeidan, Rami S. Komrokji, Jake Shortt, David Valcárcel, Anna T Jonasova, Sophie Dimicoli, Ing Soo Tiong et al. · 2024 · The Lancet Haematology
89. Maitake mushroom extract in myelodysplastic syndromes (MDS): a phase II study
    Kathleen M. Wesa, Susanna Cunningham–Rundles, Virginia M. Klimek, Emily Vertosick, Marci I. Coleton, K. Simon Yeung, Hong Lin, Stephen D. Nimer, Barrie R. Cassileth · 2014 · Cancer Immunology Immunotherapy
90. A segmentation method based on HMRF for the aided diagnosis of acute myeloid leukemia
    Jie Su, Shuai Liu, Jinming Song · 2017 · Computer Methods and Programs in Biomedicine
91. DNA-hypomethylating agents as epigenetic therapy before and after allogeneic hematopoietic stem cell transplantation in myelodysplastic syndromes and juvenile myelomonocytic leukemia
    Christian Flotho, Sebastian Sommer, Michael Lübbert · 2017 · Seminars in Cancer Biology
92. Philadelphia-negative myeloproliferative neoplasms as disorders marked by cytokine modulation
    Cacemiro, Maira da Costa, Cominal, Juçara Gastaldi, Tognon, Raquel, Nunes, Natalia de Souza, Simões, Belinda Pinto, Figueiredo-Pontes, Lorena Lôbo de, Catto, Luiz Fernando Bazzo, Traina, Fabíola, Souto, Elizabeth Xisto, Zambuzi, Fabiana Albani et al. · 2018 · Hematology, Transfusion and Cell Therapy
93. Mutation-specific signaling profiles and kinase inhibitor sensitivities of juvenile myelomonocytic leukemia revealed by induced pluripotent stem cells
    Sarah Kathleen Tasian, Jessica A. Casas, David F. Posocco, Shilpa Gandre-Babbe, Alyssa L. Gagne, Ge Liang, Mignon L. Loh, Mitchell J. Weiss, Deborah L. French, Stella T. Chou · 2018 · Leukemia
94. Impact of somatic and germline mutations on the outcome of systemic mastocytosis
    Javier I. Muñoz‐González, María Jara‐Acevedo, Iván Álvarez‐Twöse, Jason D. Merker, Cristina Teodósio, Yanli Hou, Ana Henriques, Krishna M. Roskin, Laura Sánchez‐Muñoz, Albert G. Tsai et al. · 2018 · Blood Advances
95. Characteristics of patients with myeloproliferative neoplasms with lymphoma, with or without JAK inhibitor therapy
    Naveen Pemmaraju, Hagop M. Kantarjian, Loretta J. Nastoupil, Megan Dupuis, Lisa Zhou, Sherry A. Pierce, Keyur Pravinchandra Patel, Lucia Masárová, Jörge E. Cortes, Srđan Verstovšek · 2019 · Blood
96. Relapses and treatment-related events contributed equally to poor prognosis in children with ABL-class fusion positive B-cell acute lymphoblastic leukemia treated according to AIEOP-BFM protocols
    Gunnar Cario, Veronica Leoni, Valentino Conter, Andishe Attarbaschi, Marketa Kubricanova Zaliova, Lucie Šrámková, Giovanni Cazzaniga, Grazia Fazio, Rosemary Sutton, Sarah Elitzur et al. · 2019 · Haematologica
97. Classic and Variants APLs, as Viewed from a Therapy Response
    Marie‐Claude Geoffroy, Hugues de Thé · 2020 · Cancers
98. Anemia as the Main Manifestation of Myelodysplastic Syndromes
    Santini, Valeria · 2015 · Seminars in Hematology
99. Heterogeneity in myeloproliferative neoplasms: Causes and consequences
    Jennifer O’Sullivan, Adam J. Mead · 2018 · Advances in Biological Regulation
100. Prognostic and predictive value of a microRNA signature in adults with T-cell lymphoblastic lymphoma
     Xiao-Peng Tian, Wei-Juan Huang, Hui-Qiang Huang, Yan Hui Liu, Liang Wang, Xi Zhang, Tong-Yu Lin, Hui‐Lan Rao, Mei Li, Fang Liu et al. · 2019 · Leukemia